Cherington Charles bought ERNA
February 10, 2026 · Form 4 insider transaction
Cherington Charles bought 4,000,000 shares of Ernexa Therapeutics Inc. at $0.50 per share, a transaction worth $2.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000,000
Price
$0.50
Total value
$2.00M
InsiderCherington Charles
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 10, 2026
Filing dateFebruary 17, 2026
Shares owned after6,779,440
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares and warrants were purchased by the reporting person in the Issuer's follow-on offering pursuant to a prospectus supplement dated February 6, 2026, which closed on February 10, 2026.; The combined purchase price in the Offering per share of Common Stock and accompanying warrant was $0.50.